-
21 October 2022 - HIPGEN Final Meeting – Public Session
Final HIPGEN Annual Meeting, 12-13 September 2022 in Brussels Atomium Pl. de l’Atomium 1 1020 Brussels, Belgium PUBLIC SESSION VIDEO Public session Chair: Tobias Winkler Charité Universitätsmedizin Berlin, Germany Hip fracture, medical need and ra onal for regenerative treatments PLX PAD cells characteris cs HIPGEN Clinical Study Challenges and data […]
Read More → -
8 June 2022 - PACE Final Live Meeting
PACE Final Live Meeting: overview of PACE project and clinical study results. The meeting was held on 8 June at 17:00 CET. Agenda Welcome Into CLI disease and problem. The rationale for PLX-PAD treatment – Norbert Weiss PLX-PAD cells characteristics – Guido Moll, Hans-Dieter Volk PACE Clinical Study – Challenges […]
Read More → -
26 October 2021 - RESTORE ORIGINAL RESEARCH article on frontiersin.org
Frontiers | RESTORE Survey on the Public Perception of Advanced Therapies and ATMPs in Europe – Why the European Union Should Invest More! | Medicine (frontiersin.org) Advanced therapy medicinal products (ATMPs) are potential game changers in modern medical care with an anticipated major impact for patients and society. They are […]
Read More → -
14 September 2021 - Gene Therapy 2.0 Webinar
RESTORE looks forward to welcoming you to the Gene Therapy 2.0 29 September 2021 – Webinar event RESTORE will be hosting a half-day online seminar entitled Gene Therapy 2.0 on 29th September 2021 with the intention of engaging and informing academic and industry institutions as well as patient networks, about the […]
Read More → -
21 May 2021 - RESTORE Research
Bringing Advanced Therapy Medicinal Products (ATMPs) to the clinic and beyond: How to ensure the sustainable and affordable introduction of ATMPs into healthcare Advanced Therapy Medicinal Products (ATMPs) have huge potential to be game changers in the treatment of chronic diseases. The deadline for manuscript submission to the RESTORE Frontiers […]
Read More →
LATEST NEWS